Monthly Archives: September 2016


Pfizer gains ground in cholesterol antibody chase

Pfizer has put on a late spurt in the race to bring a PCSK9 blocker class to market, reporting positive phase 2b data for bococizumab, which has now entered late-stage testing. Results from the 24-week study show that bococizumab (RN316) was significantly better than placebo in reducing elevated LDL-cholesterol, a major risk factor for cardiovascular [...]

By | September 20th, 2016|Uncategorized|0 Comments

What would Brexit mean for recruiting talent?

By heralding Britain’s withdrawal from the principle of free movement of workers, Brexit could make it more difficult for brands to recruit talent from EU countries. In a letter to staff earlier this year, Rolls-Royce CEO Torsten Müller-Ötvös warned that Brexit would affect the company’s hiring capabilities, as […]

By | September 20th, 2016|Uncategorized|0 Comments